Taltz (Ixekizumab)

Ixekizumab is a medicine used to treat psoriasis and some kinds of arthritis that affect the joints and spine. It is given as a shot under the skin. It works by blocking a protein that causes swelling and irritation in the body.

Brand names:Taltz
Medication

What people taking Taltz (Ixekizumab) report

Every report comes from a Lived member, sent anonymously.

Have you tried Taltz (Ixekizumab) for Psoriasis?

NameHow it went

About Taltz (Ixekizumab)

What It's For

Ixekizumab, sold as Taltz, is an injected prescription medicine for several related inflammatory conditions. It treats moderate to severe plaque psoriasis, the raised, scaly patches of skin psoriasis, in adults and children 6 and older who need more than creams or ointments, meaning they are candidates for whole-body (systemic) treatment or light therapy. In adults, it is also approved for active psoriatic arthritis, the joint inflammation that affects some people with psoriasis, where it can be used alone or alongside methotrexate. It also treats two forms of axial spondyloarthritis, an inflammatory arthritis that mainly affects the spine and the joints of the pelvis: ankylosing spondylitis, where damage shows on X-rays, and non-radiographic axial spondyloarthritis, where X-rays look normal but tests still show signs of active inflammation. Taltz is a biologic, a medicine made from living cells, and is usually considered when standard treatments have not controlled the condition well enough.

How It Works

In psoriasis and these forms of arthritis, the immune system keeps sending inflammatory signals that it should switch off. One of the most important is a chemical messenger called interleukin-17A (IL-17A). It drives skin cells to multiply too fast, which builds up thick, scaly plaques, and it fuels inflammation in joints and where tendons attach to bone. Ixekizumab is a monoclonal antibody, a lab-made protein designed to lock onto one specific target. It binds to IL-17A and stops it from reaching its receptor on cells, which dampens the chain of inflammation that follows. Because IL-17A also helps the body fight certain infections, particularly fungal infections of the skin and mouth, blocking it explains both the benefit and some of the side effects.

Dosage & Administration

Taltz is injected under the skin of the thigh or abdomen, or the back of the upper arm when someone else gives it. It comes as a single-dose autoinjector pen or prefilled syringe. Adults can inject themselves at home after training from the care team. Treatment begins with a larger starting dose given as two injections. For adult plaque psoriasis, one injection follows every 2 weeks until week 12, and then every 4 weeks after that. For psoriatic arthritis and ankylosing spondylitis, the starting dose is followed by one injection every 4 weeks; someone who has both psoriatic arthritis and moderate to severe psoriasis usually follows the psoriasis schedule. Non-radiographic axial spondyloarthritis starts directly with one injection every 4 weeks. Children with psoriasis receive a dose based on weight every 4 weeks, given by a healthcare provider or a trained adult caregiver rather than by the child. Keep the pens or syringes in the refrigerator in their carton, away from light, and do not freeze or shake them. Let one sit out for about 30 minutes before injecting. If needed, a pen can stay at room temperature for up to 5 days, but it should not go back in the refrigerator. Avoid injecting into skin that is tender, bruised, red, hard or affected by psoriasis. If a dose is missed, inject it as soon as you remember, then return to the usual schedule.

Side Effects

Reactions where the shot was given, usually redness and pain, are the most common side effect. They are mostly mild and rarely a reason to stop. Colds and other upper respiratory infections, nausea, and fungal infections such as athlete's foot, ringworm or thrush (white patches in the mouth) are also more common than without the medicine. Because Taltz weakens part of the immune response, serious infections can occur, though they are uncommon. Call the care team right away for signs of infection such as fever, sweats or chills, a cough or shortness of breath that will not settle, warm, red or painful skin, or burning when urinating. Some people develop a severe rash that looks like eczema, with itching, dry or leathery skin, or blisters that ooze or crust. It can start days to months after the first dose and should be reported, since treatment may need to pause. Serious allergic reactions are rare. Get emergency help by calling 911 for swelling of the face, lips, tongue or throat, trouble breathing, chest or throat tightness, or feeling faint after an injection, and do not take another dose.

Interactions & Warnings

Before starting, you will be tested for tuberculosis (TB), a lung infection that can stay dormant for years. Taltz is not started during active TB, and a dormant infection is usually treated first. Anyone who has had a severe allergic reaction to ixekizumab or its ingredients should not use it. Tell the prescriber about any infection that keeps coming back. Taltz can trigger or worsen inflammatory bowel disease, meaning Crohn's disease or ulcerative colitis. People who already have one of these conditions need a careful discussion, because a different medicine may suit them better. During treatment, report new or worsening stomach pain, diarrhea (with or without blood) or unexplained weight loss. Live vaccines, which contain a weakened form of a germ, should be avoided during treatment, so ask before any vaccination. Ideally, routine vaccinations are brought up to date before the first dose. Tell the care team about every medicine and supplement you take. There is not enough information to know whether Taltz affects a pregnancy or passes into breast milk. Antibodies like this one can cross the placenta, so anyone pregnant, planning a pregnancy or breastfeeding should weigh the options with their prescriber.

What to Expect

Psoriasis often improves noticeably within the first few months. In the main trials, most adults had at least a 75% improvement in their skin by week 12, and over a third had completely clear skin. Itching usually eased along with the plaques. Joint and back symptoms in arthritis and spondyloarthritis are generally judged over a few months of treatment. Not everyone responds well, and some people do better on a different biologic. Taltz controls these conditions rather than curing them. In a study of people whose psoriasis cleared, most stayed clear while continuing injections every 4 weeks, but most lost that response within a year after switching to placebo. For most people this is a long-term treatment, with regular check-ins to review how well it is working, watch for infections and bowel symptoms, and decide whether to continue.

Questions to Ask Your Doctor

  1. 1.Why is Taltz a good fit for me compared with other biologics or pills, and what should we do if it does not work well enough?
  2. 2.How and when will we judge whether my skin, joints or back are responding?
  3. 3.Do I need a TB test or any vaccines before I start, and which vaccines should I avoid while on it?
  4. 4.I have (or have had) bowel problems, eczema or frequent infections: does that change whether Taltz is right for me?
  5. 5.What should I do if I get sick, need surgery, or become pregnant while taking it?

Last reviewed • Oct 2026

Educational content, not medical advice.